PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
54.43%
Revenue growth 50-75% of VET's 77.56%. Martin Whitman would scrutinize if slower growth is temporary.
107.49%
Cost growth above 1.5x VET's 61.00%. Michael Burry would check for structural cost disadvantages.
5.28%
Gross profit growth below 50% of VET's 81.44%. Michael Burry would check for structural issues.
-31.82%
Margin decline while VET shows 2.18% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.94%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-134.85%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-3.03%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
-48.89%
D&A reduction while VET shows 6.98% growth. Joel Greenblatt would examine efficiency.
49.61%
EBITDA growth below 50% of VET's 184.62%. Michael Burry would check for structural issues.
68.18%
EBITDA margin growth 1.25-1.5x VET's 60.29%. Bruce Berkowitz would examine sustainability.
492.56%
Operating income growth 1.25-1.5x VET's 378.42%. Bruce Berkowitz would examine sustainability.
283.71%
Operating margin growth exceeding 1.5x VET's 169.44%. David Dodd would verify competitive advantages.
150.63%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
286.57%
Pre-tax income growth below 50% of VET's 578.48%. Michael Burry would check for structural issues.
150.32%
Pre-tax margin growth 50-75% of VET's 282.10%. Martin Whitman would scrutinize operations.
596.96%
Tax expense growth above 1.5x VET's 335.80%. Michael Burry would check for concerning trends.
557.39%
Net income growth exceeding 1.5x VET's 21.52%. David Dodd would verify competitive advantages.
325.69%
Net margin growth while VET declines. John Neff would investigate advantages.
411.11%
EPS growth exceeding 1.5x VET's 35.29%. David Dodd would verify competitive advantages.
423.22%
Diluted EPS growth exceeding 1.5x VET's 23.53%. David Dodd would verify competitive advantages.
26.55%
Share count reduction below 50% of VET's 1.19%. Michael Burry would check for concerns.
25.33%
Diluted share reduction below 50% of VET's 1.83%. Michael Burry would check for concerns.